Montana’s new “right to try” law can’t come soon enough for some

Kris DeVault's son Brody has creatine transporter deficiency, a rare genetic condition with no cure. A French biotech company, Ceres Brain Therapeutics, is developing an experimental nasal spray drug for the condition, currently in early testing phases. Montana's new 'right to try' law may help families like the DeVaults access unapproved treatments.